Total Payments
$315,594
2023 Payments
$10,179
Companies
16
Transactions
113
Payment Breakdown by Category
Research$250,604 (79.4%)
Consulting$56,624 (17.9%)
Other$6,051 (1.9%)
Food & Beverage$1,434 (0.5%)
Travel$841.02 (0.3%)
Education$40.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $250,604 | 75 | 79.4% |
| Consulting Fee | $56,624 | 9 | 17.9% |
| Honoraria | $3,900 | 2 | 1.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,151 | 1 | 0.7% |
| Food and Beverage | $1,434 | 21 | 0.5% |
| Travel and Lodging | $841.02 | 4 | 0.3% |
| Education | $40.00 | 1 | 0.0% |
Payments by Type
Research
$250,604
75 transactions
General
$64,990
38 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Orthofix Medical, Inc. | $146,713 | 53 | $0 (2023) |
| CyMedica Orthopedics, Inc. | $90,517 | 2 | $0 (2020) |
| Orthofix International N.V. | $36,991 | 19 | $0 (2017) |
| Regeneron Pharmaceuticals, Inc. | $30,293 | 16 | $0 (2020) |
| FIDIA PHARMA USA INC. | $3,659 | 5 | $0 (2018) |
| GENZYME CORPORATION | $3,638 | 4 | $0 (2018) |
| Endo Pharmaceuticals Inc. | $1,800 | 1 | $0 (2023) |
| PFIZER INC. | $1,408 | 2 | $0 (2020) |
| TISSUETECH, INC. | $149.09 | 1 | $0 (2021) |
| Medacta USA, Inc. | $121.95 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $10,179 | 3 | Orthofix Medical, Inc. ($8,344) |
| 2022 | $19,668 | 4 | Orthofix Medical, Inc. ($19,668) |
| 2021 | $19,173 | 13 | Orthofix Medical, Inc. ($18,852) |
| 2020 | $126,890 | 18 | CyMedica Orthopedics, Inc. ($90,517) |
| 2019 | $46,609 | 17 | Orthofix Medical, Inc. ($33,109) |
| 2018 | $43,649 | 33 | Orthofix Medical, Inc. ($36,760) |
| 2017 | $49,426 | 25 | Orthofix International N.V. ($36,991) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/02/2023 | GT Medical Technologies, Inc | GAMMATILE (Device) | Food and Beverage | Cash or cash equivalent | $35.32 | General |
| Category: KXK | ||||||
| 04/28/2023 | Orthofix Medical, Inc. | Spinal-Stim (Device) | Consulting Fee | Cash or cash equivalent | $8,344.00 | General |
| Category: Stimulator, Bone Growth, Non-Invasive | ||||||
| 01/11/2023 | Endo Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 11/10/2022 | Orthofix Medical, Inc. | — | Consulting Fee | Cash or cash equivalent | $596.00 | General |
| 06/09/2022 | Orthofix Medical, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,192.00 | General |
| 06/02/2022 | Orthofix Medical, Inc. | — | Consulting Fee | Cash or cash equivalent | $15,496.00 | General |
| 03/17/2022 | Orthofix Medical, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,384.00 | General |
| 11/30/2021 | Orthofix Medical, Inc. | — | — | Cash or cash equivalent | $2,384.00 | Research |
| Study: CP-1604 PSRC -EMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears | ||||||
| 11/03/2021 | DePuy Synthes Sales Inc. | CORAIL (Device) | Food and Beverage | In-kind items and services | $107.23 | General |
| Category: Ortho-Hip | ||||||
| 10/26/2021 | Orthofix Medical, Inc. | — | — | Cash or cash equivalent | $2,384.00 | Research |
| Study: CP-1604 PSRC -EMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears | ||||||
| 09/21/2021 | Orthofix Medical, Inc. | — | — | Cash or cash equivalent | $2,384.00 | Research |
| Study: CP-1604 PSRC -EMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears | ||||||
| 08/31/2021 | TISSUETECH, INC. | — | Food and Beverage | In-kind items and services | $149.09 | General |
| 08/11/2021 | Pacira Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Musculoskeletal | ||||||
| 07/22/2021 | Pacira Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Musculoskeletal | ||||||
| 05/18/2021 | Orthofix Medical, Inc. | — | — | Cash or cash equivalent | $2,340.00 | Research |
| Study: CP-1604 PSRC -EMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears | ||||||
| 04/15/2021 | Orthofix Medical, Inc. | — | — | Cash or cash equivalent | $2,340.00 | Research |
| Study: CP-1604 PSRC -EMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears | ||||||
| 03/09/2021 | Orthofix Medical, Inc. | — | — | Cash or cash equivalent | $2,340.00 | Research |
| Study: CP-1604 PSRC -EMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears | ||||||
| 02/18/2021 | Pacira Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Musculoskeletal | ||||||
| 02/09/2021 | Orthofix Medical, Inc. | — | — | Cash or cash equivalent | $2,340.00 | Research |
| Study: CP-1604 PSRC -EMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears | ||||||
| 01/26/2021 | Orthofix Medical, Inc. | — | — | Cash or cash equivalent | $2,340.00 | Research |
| Study: CP-1604 PSRC -EMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears | ||||||
| 12/10/2020 | Orthofix Medical, Inc. | Cervical-Stim Osteogenesis Stimulator (Device), Physio-Stim Osteogenesis Stimulator, Spinal-Stim Osteogenesis Stimulator | — | Cash or cash equivalent | $2,340.00 | Research |
| Study: PRSC • Category: Stimulator, Bone Growth, Non-Invasive | ||||||
| 12/01/2020 | Orthofix Medical, Inc. | Cervical-Stim Osteogenesis Stimulator (Device), Physio-Stim Osteogenesis Stimulator, Spinal-Stim Osteogenesis Stimulator | — | Cash or cash equivalent | $2,340.00 | Research |
| Study: PRSC • Category: Stimulator, Bone Growth, Non-Invasive | ||||||
| 11/20/2020 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $1,400.00 | General |
| 10/22/2020 | Regeneron Pharmaceuticals, Inc. | — | — | In-kind items and services | $2,470.13 | Research |
| Study: FASINUMAB CLINICAL PUBLICATION PROGRAM | ||||||
| 10/20/2020 | Orthofix Medical, Inc. | Spinal-Stim Osteogenesis Stimulator (Device), Physio-Stim Osteogenesis Stimulator, Cervical-Stim Osteogenesis Stimulator | — | Cash or cash equivalent | $2,340.00 | Research |
| Study: PRSC • Category: Stimulator, Bone Growth, Non-Invasive | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Evaluation of a Home-based NMES Therapy for Knee Osteoarthritis Pain (NMES) | CyMedica Orthopedics, Inc. | $90,500 | 1 |
| CP-1403PSOA | Orthofix Medical, Inc. | $36,760 | 12 |
| CP-1403PSOA | Orthofix International N.V. | $36,562 | 12 |
| PRSC | Orthofix Medical, Inc. | $29,980 | 12 |
| PSOA | Orthofix Medical, Inc. | $26,600 | 12 |
| CP-1604 PSRC -EMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears | Orthofix Medical, Inc. | $18,852 | 8 |
| PSRC | Orthofix Medical, Inc. | $6,435 | 3 |
| FASINUMAB CLINICAL PUBLICATION PROGRAM | Regeneron Pharmaceuticals, Inc. | $2,470 | 1 |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee | Regeneron Pharmaceuticals, Inc. | $957.95 | 11 |
| SOLAR | GENZYME CORPORATION | $658.00 | 1 |
| A Study of the Safety and Effectiveness of Synvisc-One? (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip (SOLAR) | GENZYME CORPORATION | $425.77 | 1 |
| MARCHE | GENZYME CORPORATION | $403.15 | 1 |
About Dr. Nebojsa Skrepnik, MD
Dr. Nebojsa Skrepnik, MD is a Internal Medicine healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2009. The National Provider Identifier (NPI) number assigned to this provider is 1447488119.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nebojsa Skrepnik, MD has received a total of $315,594 in payments from pharmaceutical and medical device companies, with $10,179 received in 2023. These payments were reported across 113 transactions from 16 companies. The most common payment nature is "" ($250,604).
Ad
Practice Information
- Specialty Internal Medicine
- Location Tucson, AZ
- Active Since 07/01/2009
- Last Updated 07/01/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1447488119
Products in Payments
- Cervical-Stim Osteogenesis Stimulator (Device) $63,431
- Spinal-Stim Osteogenesis Stimulator (Device) $38,155
- Physio-Stim Osteogenesis Stimulator (Device) $34,825
- Spinal-Stim (Device) $8,344
- Hymovis (Device) $3,659
- SYNVISC-ONE (Device) $3,638
- All Spine Stimulation (Biological) $339.29
- Efficiency (Device) $121.95
- Zilretta (Drug) $107.26
- CORAIL (Device) $107.23
- Physio-Stim (Biological) $89.58
- Nstride (Device) $40.00
- GAMMATILE (Device) $35.32
- KYPHON Balloon Kyphoplasty (Device) $14.74
- THROMBIN (Biological) $7.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tucson
Dr. Rajesh Janardhanan, Md, Mrcp, Facc, Fase, MD, MRCP, FACC, FASE
Internal Medicine — Payments: $837,483
Internal Medicine $837,483
Steven Mottl, D.o, D.O
Internal Medicine — Payments: $317,974
Internal Medicine $317,974
Jyotsna Sahni, M.d, M.D
Internal Medicine — Payments: $150,501
Internal Medicine $150,501
Dr. Neil Gheewala, M.d, M.D
Internal Medicine — Payments: $145,873
Internal Medicine $145,873
Dr. Tara Carr, M.d, M.D
Internal Medicine — Payments: $117,865
Internal Medicine $117,865
Dr. Dexter De Leon, M.d, M.D
Internal Medicine — Payments: $101,757
Internal Medicine $101,757